Integrum initiates collaboration with Erie County Medical Center in New York

Integrum develops and markets OPRA­­^TM – the only FDA approved bone-anchored treatment system for major limb loss. The use of OPRA^TM is supported by a substantial body of scientific and clinical literature showing that the system significantly improves functional outcomes, and quality of life, in individuals who have suffered limb loss.

Integrum is working to train and support clinical teams at selected key hospitals in the US, in order spread awareness of the OPRA^TM system. The collaboration with Erie County Medical Center’s (ECMC) marks an important step forward, as Integrum continues to expand its presence in the US market. ECMC, with Integrum’s support, fully completed treatment of their first two patients over a six-month period.

Integrum is also working with Garwood Medical Devices, a Buffalo based medical device company developing the microelectronic system BioPrax to mitigate implant-related infection. Integrum is continuously evaluating technologies to effectively decrease infection rates since it can help expand the use of OPRA^TM to patients more prone to infections, such as those with certain comorbidities and the elderly. In June 2021, Integrum and Garwood Medical Devices entered a memorandum of understanding to explore a collaboration aimed at expanding treatment indications for the OPRA^TM Implant System. Garwood Medical and the affiliated research team at the University at Buffalo were recently awarded a $744,000 grant from the US Department of Defense (DoD) to investigate if the BioPrax system can be used to mitigate implant-related infection. The collaboration was recently featured in a news article in Buffalo News.

“We are pleased to work with the skilled surgical and rehab team at the ECMC to successfully facilitate incorporation of the OPRA^TM implant system in their treatment offering to patients who have suffered major limb loss. We are further looking forward to collaborating with Garwood Medical Devices and hopefully find a better solution to address infection and alleviate patient suffering”, said Tom Dugan, President, Integrum Inc.

For further information, please contact:
Maria Lopez, CEO
Phone: +46 (0) 708-46 10 69
Email: maria.lopez@integrum.se

Dennis Baecklund, CFO
Phone: +46 (0) 72 556 68 69 
Email: dennis.baecklund@integrum.se

Certified Adviser:
Erik Penser Bank AB
Tel. +46 (0) 8 463 8000
Email: certifiedadviser@penser.se